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Abstract: 
A novel β-annulus peptide of Sesbania mosaic virus bearing an FKFE sequence at the 
C terminus was synthesized, and its self-assembling behavior in water was investigated. 
Dynamic light scattering and transmission electron microscopy showed that the β-annulus 
peptide bearing an FKFE sequence self-assembled into approximately 30 nm nanospheres 
in water at pH 3.8, whereas the β-annulus peptide without the FKFE sequence afforded 
only irregular aggregates. The peptide nanospheres possessed a definite critical 
aggregation concentration (CAC = 26 µM), above which the size of nanospheres were 
nearly unaffected by the peptide concentration. The formation of peptide nanospheres 
was significantly affected by pH; the peptide did not form any assemblies at pH 2.2 
whereas larger aggregates were formed at pH 6.4–11.6. 
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INTRODUCTION 
In biological systems, many nanostructures consisting of proteins are formed 
spontaneously through self-assembly. Spherical viral capsids and clathrin lattices are 
good examples of natural protein assemblies with a discrete size and they have attracted 
much attention as biomaterials for nanocarriers.1-3 Most spherical viral capsids have an 
icosahedral symmetry and are formed by the self-assembly of multiples of 60 protein 
subunits.4 A clathrin lattice is formed by the self-assembly of C3-symmetric protein 
subunits (triskelion) in the presence of Mg2+ ions.5, 6 
Recently, chemical strategies for the rational design of artificial proteins and peptides 
have been progressively developed for the construction of self-assembled 
nanostructures.7, 8 Many artificial supramolecular assemblies consisting of coiled-coil α-
helix peptides9-13 and β-sheet-forming peptides14-19 have been reported. For example, 
Woolfson and coworkers demonstrated that two complementary coiled-coil bundles self-
assembled into approximately 100 nm unilamellar spheres.20 Jerala and coworkers 
developed a folding strategy for the construction of discrete tetrahedral nanostructures 
with a single-chain coiled-coil peptide.21 We developed C3-symmetric, β-sheet-forming 
peptide conjugates22-25 and glutathione conjugates,25-28 which self-assembled into viral-
size spherical nanostructures in water. 
Tomato bushy stunt virus (TBSV) capsids are formed by the self-assembly of 180 
quasi-equivalent protein subunits containing 388 amino acids each and possess a 
dodecahedral internal skeleton composed of a C3-symmetric β-annulus motif.4, 29, 30 We 
demonstrated that the synthetic 24-mer β-annulus peptide fragment 
(INHVGGTGGAIMAPVAVTRQLVG) of TBSV spontaneously self-assembled into 
virus-like nanocapsules in water.31-34 The β-annulus motif was also found in other 
spherical viral capsids such as Sesbania mosaic virus (SeMV),35, 36 desmodium yellow 
mottle tymovirus,37 ryegrass mottle virus,38 cucumber necrosis virus,39 tobacco necrosis 
virus,40 and turnip yellow mosaic virus.41 SeMV capsids are formed through the self-
assembly of 180 quasi-equivalent protein subunits composed of pentameric A and 
pseudo-hexameric B/C subunits.35, 36 The β-annulus motif of SeMV consists of a 12-mer 
peptide (GISMAPSAQGAM) and exists at the center of the C subunit trimer (Figure 1). 
Herein, we employed a 12-mer β-annulus peptide of SeMV as a novel self-assembling 
peptide motif for constructing virus-like particles. As the 12-mer β-annulus peptide 
mainly consists of hydrophobic residues, it was expected that the 12-mer peptide would 
have poor solubility in water. Thus, we designed a novel β-annulus peptide of SeMV with 
an FKFE sequence at the C terminus as a self-assembling unit (1: 
GISMAPSAQGMFKFE, Figure 1). In this paper, we report the self-assembling behavior 
of the 16-mer modified β-annulus peptide of SeMV (1) and the 12-mer β-annulus peptide 
without the FKFE sequence (2). 
 
MATERIALS AND METHODS 
Reagents were obtained from commercial sources and used without further 
purification. Reversed-phase HPLC was performed at ambient temperature on a 
Shimadzu LC-6AD liquid chromatograph equipped with a UV–vis detector (220 nm, 
Shimadzu SPD-20A) and GL Science Inertsil WP300 C18 (4.6 × 250 mm2 and 20 × 250 
mm2) columns. MALDI-TOF mass spectra were obtained on an Autoflex III (Bruker 
Daltonics) spectrometer operated under the linear/positive mode with α-cyano-4-hydroxy 
cinnamic acid (α-CHCA) as the matrix. CD spectra were collected in a 1 mm quartz cell 
with a JASCO J-820 spectrophotometer at 25 °C. 
 
Synthesis of peptide 1. 
The protected peptide H-Gly-Ile-Ser(tBu)-Met-Ala-Pro-Ser(tBu)-Ala-Gln(Trt)-Gly-
Ala-Met-Phe-Lys(Boc)-Phe-Glu(OtBu)-Alko resin was synthesized on an Fmoc-
Glu(OtBu)-Alko resin (Fmoc = 9-fluorenylmethoxycarbonyl, Watanabe Chemical Ind., 
Ltd., 0.51 mmol/g) using Fmoc-based coupling reactions. A solution of 1-
[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate (HATU, 4 equiv) and diisopropylamine (8 equiv) in N-
methylpyrrolidone (NMP) was used for coupling. A solution of 20% piperidine in N,N-
dimethylformamide (DMF) was used for Fmoc deprotection. The progress of the coupling 
reaction and Fmoc deprotection was confirmed using a TNBS Test Kit (Tokyo Chemical 
Industry Co., Ltd.). The peptidyl resin was washed with NMP. 
The peptide was deprotected and cleaved from the resin by treatment with a mixture 
of trifluoroacetic acid (TFA)/water/1,2-ethanedithiol/triisopropylsilane 
(9.45/0.25/0.25/0.1) at room temperature for 6 h. The cleavage mixture was filtered to 
remove the resin and the filtrate was concentrated under vacuum. The peptide was 
precipitated upon addition of methyl tert-butyl ether (MTBE) to the residue and the 
supernatant was decanted. After the peptide was washed three times with MTBE, the 
precipitated peptide was dried under vacuum. The crude product was purified by 
reversed-phase HPLC (Inertsil WP300 C18), eluting with a linear gradient of 
CH3CN/water containing 0.1% TFA (24/76 to 30/70 over 100 min). The fraction 
containing the desired peptide was lyophilized to give 1.66 mg of 1 as a flocculent solid 
(17% yield). MALDI-TOF-MS (matrix: α-CHCA): m/z = 1673 [M + H]+, 1711 [M + K]+. 
 
Synthesis of peptide 2. 
Peptide 2 (GISMAPSAQGM) was synthesized by nearly the same procedure as 
described above. This gave a yield of 8.2% for 2. MALDI-TOF-MS (matrix: α-CHCA): 
m/z = 1121 [M + H]+, 1143 [M + Na]+, 1159 [M + K]+. 
 
Dynamic light scattering (DLS) measurements. 
DLS measurements were performed using a Zetasizer NanoZS (MALVERN 
Instruments, Ltd.) instrument at 25 °C with an incident He−Ne laser (633 nm). During 
measurement, the count rate (sample-scattering intensity) was also provided. The 
correlation time for the scattered light intensity (G(τ)) was measured several times and 
the averaged results were fitted to equation 1:  
 G(τ) = B + A exp(−2q2Dτ)                        (1) 
where B is the baseline, A is the amplitude, q is the scattering vector, τ is the delay time, 
and D is the diffusion coefficient. The hydrodynamic radius (RH) of the scattering 
particles was calculated using the Stokes−Einstein equation (eq. 2):  
(2) 
 
 
where η is the solvent viscosity, kB is the Boltzmann constant, and T denotes the absolute 
temperature. 
 
Transmission electron microscopy (TEM). 
A carbon-coated Cu-grid (Oken Co., Ltd.) was hydrophilized for 30 s with a 
hydrophilization treatment apparatus (JEOL HDT-400). An aliquot (10 µL) of an aqueous 
solution of peptide 1 was applied to a hydrophilized carbon-coated grid, left for 60 s, and 
removed. A drop of 2 wt% aqueous ethidium bromide was then placed on the grids. After 
the sample-loaded carbon-coated grids were dried in vacuo, they were observed by TEM 
(JEOL JEM-2010) using an acceleration voltage of 120 kV. 
 
Scanning electron microscopy (SEM). 
An aliquot (10 µL) of an aqueous solution of peptide 1 was applied to a hydrophilized 
carbon-coated grid, left for 60 s, and removed. The grids were dried in vacuo and coated 
with platinum (3 nm, Hitachi E-1030 ion sputter). The grids were then subjected to SEM 
observation (Hitachi S-5000) with an acceleration voltage of 15 kV. 
 
RESULTS AND DISCUSSION 
Synthesis of modified β-annulus peptide of SeMV 
The 16-mer β-annulus peptide of SeMV modified with the β-sheet-forming sequence 
FKFE (1) and the 12-mer β-annulus peptide without the FKFE sequence (2) were 
synthesized by Fmoc solid-phase peptide synthesis in 17% and 8.2% yields, respectively. 
These peptides were purified by reversed-phase HPLC and confirmed by MALDI-TOF 
mass spectrometry (1: m/z = 1673 [M + H]+; 2: m/z = 1121 [M + H]+). A lyophilized 
powder of peptide 1 readily dissolved in deionized water at 3 mM without heating, 
whereas a lyophilized powder of peptide 2 hardly dissolved in deionized water even at 
0.1 mM. Peptide 2 was able to be dissolved in water in the presence of 0.3% 2,2,2-
trifluoroethanol (TFE) at 0.1 mM. The poor solubility of 2 in water can be ascribed to the 
ten hydrophobic and two nonionic hydrophilic residues in the sequence. In contrast, the 
good solubility of peptide 1 in water can be ascribed to the addition of ionic residues K 
and E. An aqueous solution of peptide 1 at 0.5 mM had a pH value of 3.8. The CD 
RH = 
kBT 
6πηD 
spectrum of this solution showed a negative peak at 197 nm and a negative shoulder at 
approximately 220–240 nm (Figure 2), which is similar to that of the 24-mer β-annulus 
peptide of TBSV reported previously,31 indicating the existence of random coils, β-
structures, and turn structures.  
 
Self-assembly of modified β-annulus peptide 
The DLS of the aqueous solution of peptide 1 (0.5 mM, pH 3.8) showed the formation 
of monodispersed assemblies with 32 ± 8 nm hydrodynamic diameters (Figure 3a), which 
is comparable to that of natural SeMV (30 nm). In contrast, the DLS of the aqueous 
solution of peptide 2 (0.1 mM containing 0.3% TFE) showed the formation of 
multidispersed assemblies of 20–400 nm (Figure 3b). TEM (Figure 4a) and SEM (Figure 
4c) images of the aqueous solution of peptide 1 also showed the presence of 19–62 nm 
spherical assemblies. The average diameter of the assemblies was determined to be 33 ± 
10 nm, according to the size distribution obtained from the TEM images, which 
corresponds to the hydrodynamic diameter determined by DLS. Conversely, only 
irregular aggregates over 1 µm were observed in the SEM image of the aqueous solution 
of peptide 2 (Figure 4d). Thus, the 12-mer β-annulus peptide of SeMV in water self-
assembled into irregular aggregates, whereas that of the 16-mer β-annulus peptide 
modified with FKFE self-assembled into closed, viral-size nanospheres. The difference 
in the self-assembling behavior can be ascribed to the participation of the FKFE sequence, 
which acts as not only an ionic segment but also a regulation unit for self-assembly. Since 
the β-annulus sequence in C subunit of natural SeMV capsid can form the spherical 
structure with the assistance of B subunit, it seems that 12-mer β-annulus peptide 2 alone 
could not form spherical structures. It is probable that the peptide 2 might form trigonal 
β-annulus structure, which aggregate due to the hydrophobic character in the aqueous 
solution.  
 
Effect of concentration and pH on self-assembly 
The concentration dependence of the aqueous solution of peptide 1 (pH 3.8) on 
scattering intensity (Figure 5a) revealed that the CAC at 25 °C is approximately 26 µM, 
which is comparable to that of the 24-mer β-annulus peptide of TBSV in water.31 Figure 
5b shows the concentration dependence of peptide 1 on the hydrodynamic diameter 
determined by DLS. Similar assemblies of approximately 30–40 nm were observed at 
concentrations above 0.1 mM, whereas larger assemblies (78 ± 28 nm) were observed at 
0.05 mM. At concentrations below CAC (26 µM), DLS autocorrelation data suitable for 
analysis could not be obtained, indicating minimal assemblies. Therefore, the size of the 
assemblies is marginally affected by concentrations above CAC, indicating that 30–40 
nm assemblies are stable. 
Figure 6 shows the pH dependence of peptide 1 (0.1 mM) on the hydrodynamic 
diameter determined by DLS. As described above, peptide 1 formed spherical assemblies 
with 32 ± 8 nm hydrodynamic diameters in aqueous solution at pH 3.8. In contrast, at pH 
2.2, the average diameter as determined by DLS was 2.3 ± 0.8 nm, indicating the absence 
of self-assembled structures. At pH 6.4, 8.2, and 11.6, meanwhile, DLS showed formation 
of larger assemblies. The pH dependence of the self-assembling behavior of peptide 1 can 
be ascribed to the difference in peptide charge. From the pKa values of each dissociation 
group, it is expected that the C terminus of peptide 1 possesses a zwitterionic structure at 
pH 3.8, cationic charge at pH 2.2, and anionic charge at pH 6.4–11.6. Thus, it seems that 
the zwitterionic structure at the C terminus of peptide 1 is critical for the formation of 
viral-size monodispersed assemblies, with a cationic or anionic C terminus disturbing the 
assembly of peptide 1. The pH dependence of self-assembly of peptide 1 is a contrast to 
that of 24-mer β-annulus peptide from TBSV, which form nanocapsules over a wide pH 
range (pH 2-13).32  
 
CONCLUSIONS 
We have demonstrated that a novel β-annulus peptide from SeMV bearing an FKFE 
sequence at the C terminus self-assembled into virus-like nanospheres. The size of the 
virus-like nanospheres was minimally affected by peptide concentration above CAC, but 
was drastically changed by pH. We propose that β-annulus motifs of various viruses 
modified by proper molecular design could be applied as building blocks for virus-like 
nanospheres. The present molecular design provides novel guidelines for the design of 
pH-responsive peptide nanospheres, which can be applied as drug carriers. 
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FIGURE 1 Schematic illustration of the hypothesized formation of a nanosphere through 
self-assembly of the modified β-annulus peptide of SeMV. Reproduced with permission 
from ref. 36. Copyright 2005, Elsevier. 
 
  
  
FIGURE 2 CD spectrum of an aqueous solution of peptide 1 (0.5 mM, pH 3.8) at 25 °C. 
 
  
 
FIGURE 3 Size distribution of aqueous solutions of (a) peptide 1 (0.5 mM, pH 3.8) and 
(b) peptide 2 (0.1 mM containing 0.3% TFE) determined by DLS at 25 °C.  
 
  
 FIGURE 4 (a) TEM images of the assemblies obtained from an aqueous solution of 
peptide 1 (0.5 mM, pH 3.8) and (b) the size distribution determined from TEM. SEM 
images of the assemblies obtained from an aqueous solution of (c) peptide 1 (0.5 mM, pH 
3.8) and (d) peptide 2 (0.1 mM containing 0.3% TFE). 
  
 
FIGURE 5 Effect of peptide concentration on scattering intensity (a) and size distribution 
(b) of an aqueous solution (pH 3.8) of peptide 1 determined by DLS at 25 °C. 
 
  
 
FIGURE 6 Effect of pH on the size distribution of an aqueous solution of peptide 1 (0.5 
mM) determined by DLS at 25 °C. 
